Real-world evaluation of access-driven Canadian treatment sequences in progressive prostate cancer (REACTIVATE)

CONCLUSIONS: Significant heterogeneity exists in the management and outcomes of mCRPC between provinces, particularly regarding the placement of Ra-223 in the treatment sequence.PMID:38466865 | DOI:10.5489/cuaj.8620

Source: Canadian Urological Association Journal - March 11, 2024 Category: Urology & Nephrology Authors: Jenny J Ko Lawrence Mbuagbaw Scott Tyldesley Jennifer Lowther Katherine Sunderland Catherine Royer Mareva Faure Corin MacPhail Shoaib Faizi Winson Y Cheung Richard Lee-Ying Source Type: research